Tom Keith-Roach

Tom Keith-Roach is the UK president of AstraZeneca, a leading global biopharmaceutical company. He has recently been in the news for announcing AstraZeneca's decision to pause a £200 million investment in Cambridge, attributing the challenging business environment in the UK to pressures from the US, particularly from President Trump.